肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
Cancer Research and Clinic
2015年
10期
714-716
,共3页
癌,非小细胞肺%复发%放射疗法
癌,非小細胞肺%複髮%放射療法
암,비소세포폐%복발%방사요법
Carcinoma,non-small-cell lung%Recurrence%Radiotherapy
ⅢA-N2期非小细胞肺癌术后复发率高达30％～ 60％,直接影响到患者生存期.能否将术后放疗对局部控制率的提高转化为生存获益是研究者关注的重点,但术后放疗一直存在争议,原因有两点:一是在旧放疗技术条件下放疗毒副作用抵消了生存获益,二是放疗适应证的把握,如何筛选出真正受益人群,对术后放疗地位的确立有着非常重要的意义.
ⅢA-N2期非小細胞肺癌術後複髮率高達30％～ 60％,直接影響到患者生存期.能否將術後放療對跼部控製率的提高轉化為生存穫益是研究者關註的重點,但術後放療一直存在爭議,原因有兩點:一是在舊放療技術條件下放療毒副作用牴消瞭生存穫益,二是放療適應證的把握,如何篩選齣真正受益人群,對術後放療地位的確立有著非常重要的意義.
ⅢA-N2기비소세포폐암술후복발솔고체30％～ 60％,직접영향도환자생존기.능부장술후방료대국부공제솔적제고전화위생존획익시연구자관주적중점,단술후방료일직존재쟁의,원인유량점:일시재구방료기술조건하방료독부작용저소료생존획익,이시방료괄응증적파악,여하사선출진정수익인군,대술후방료지위적학립유착비상중요적의의.
The postoperative recurrence rate of ⅢA-N2 non-small-cell lung cancer (NSCLC) is as high as 30 ％ to 60 ％, which will affect the survival period of patients.Postoperative radiotherapy to improve local control rate on prolonging survival is the research focus, but postoperative radiotherapy has been controversial.The reasons includes the old radiotherapy technology induces many side effects which reduce the survival benefit, and how to select patients with postoperative radiotherapy is very important to establish the position of postoperative radiotherapy.
